Skip to search formSkip to main contentSkip to account menu

CI 920

Known as: CI-920 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryBiochemical studies on a new antitumor antibiotic, CI-920, have been directed toward understanding its mode of action. The… 
2003
2003
The total synthesis of an antitumor antibiotic, fostriecin (CI-920), via a highly convergent route is described. A characteristic… 
2002
2002
Fostriecin, a potent and promising antitumor antibiotic, was stereoselectively synthesized via a convergent route involving a… 
Review
2002
Review
2002
A review of the current status of the chemistry and biology of fostriecin (CI-920) is provided. Fostriecin is a structurally… 
Highly Cited
2001
Highly Cited
2001
Fostriecin (CI-920, 1; see Scheme 1) is a structurally interesting antitumor agent that was first isolated in 1983 by scientists… 
Highly Cited
2001
Highly Cited
2001
The first total synthesis of the potent antitumor agent fostriecin (CI-920) is described, confirming the relative and absolute… 
Highly Cited
1984
Highly Cited
1984
Cl-920 is a structurally novel phosphate ester antibiotic that contains an unsaturated lactone and a conjugated triene system. It… 
Highly Cited
1983
Highly Cited
1983
A complex of structurally related compounds that exhibit in vivo antileukemic activity was isolated from fermentation broths of a… 
Highly Cited
1983
Highly Cited
1983
CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete…